Results 271 to 280 of about 473,635 (345)
Population-Based Estimates of Hepatitis E Virus-Associated Mortality in Bangladesh. [PDF]
Paul RC +12 more
europepmc +1 more source
Seroprevalencia de virus hepatitis E en donantes de sangre en un hospital universitario en Chile.
Natalia Covarrubías +7 more
openalex +1 more source
What's New? Oncolytic viruses are a promising immunotherapeutic approach against many malignancies. However, it is unclear whether repeated doses have improved therapeutic value or may trigger greater side effects, especially in patients with hepatocellular carcinoma whose liver is chronically damaged.
Karen J. Scott +10 more
wiley +1 more source
High hepatitis E virus prevalence in pig slurry samples from the north-western region of Germany. [PDF]
Hinte F +6 more
europepmc +1 more source
External cephalic version outcomes with tocolysis and sedation: A 10‐year retrospective cohort study
Abstract Objective To evaluate the effectiveness and safety of external cephalic version (ECV) performed with tocolysis and sedation or spinal anesthesia, and to identify predictors of ECV success, complications, and delivery outcomes after successful ECV. Methods This 10‐year cohort study included 990 pregnant women with term non‐cephalic presentation
Javier Sánchez‐Romero +7 more
wiley +1 more source
Cholestasis in hepatitis E virus infection. [PDF]
Kanda T +6 more
europepmc +1 more source
This retrospective study analyzes the deferral reasons for 148,282 blood donors during 2019–2023 (overall deferral rate: 12.37%), identifying primary deferral reasons (e.g., elevated ALT for temporary deferral at 51.33%, HBsAg positivity for permanent deferral at 4.12%).
Limei Feng +5 more
wiley +1 more source
Exacerbation of Anti-Cytomegalovirus Immunity and Mobilization of γ9δ1 T Cells During the Acute Phase of Hepatitis E Virus Infection. [PDF]
Retailleau M +5 more
europepmc +1 more source

